Concepedia

Author

Lawrence D. Kaplan

University of California, San FranciscoORCID

Also Known As

L D Kaplan, L KAPLAN, L Kaplan, L. D. Kaplan, L. Kaplan, L.D. Kaplan, Lawrence D Kaplan, Lawrence D. Kaplan, Lawrence David Kaplan, Lawrence Kaplan

183

Publications

6.6K

Citations

40

H-Index

61

Concepts

All Affiliations

University of California, San FranciscoMemorial Sloan Kettering Cancer CenterCornell UniversityUCSF Helen Diller Family Comprehensive Cancer CenterSan Francisco General Hospital
LD

About

Lawrence D. Kaplan is an author at University of California, San Francisco specializing in medicine, immunology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

27

2K

2

Health Sciences

7

7

189

3

Blood Transplantation

3

3

49

4

Allergy

1

1

37

5

Cardiothoracic Surgery

1

1

23

Lawrence D. Kaplan

×

62

Publications

5.6K

Citations

36

H-Index

YearCitations

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

Donald W. Northfelt, Bruce J. Dezube, James Thommes,

Journal of Clinical Oncology

1998

639

Intensive Chemotherapy and Immunotherapy in Patients With Newly Diagnosed Primary CNS Lymphoma: CALGB 50202 (Alliance 50202)

James L. Rubenstein, Eric D. Hsi, Jeffrey L. Johnson,

Journal of Clinical Oncology

2013

489

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010

Lawrence D. Kaplan

Blood

2005

413

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

Lawrence D. Kaplan, David J. Straus, Marcia A. Testa,

New England Journal of Medicine

1997

378

Chemotherapy for Human Immunodeficiency Virus–Associated Non-Hodgkin’s Lymphoma in Combination With Highly Active Antiretroviral Therapy

Lee Ratner, Jeannette Y. Lee, Shenghui Tang,

Journal of Clinical Oncology

2001

278

Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma

Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan,

Blood

2009

255

CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma

James L. Rubenstein, Valerie S. Wong, Cigall Kadoch,

Blood

2013

212

Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial.

Lawrence D. Kaplan, James O. Kahn, Suzanne M. Crowe,

Journal of Clinical Oncology

1991

196

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.

David J. Straus, J. Huang, Marcia A. Testa,

Journal of Clinical Oncology

1998

161

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

William G. Wierda, John C. Byrd, Jeremy S. Abramson,

PubMed

2020

143

Page 1